You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

CLINICAL TRIALS PROFILE FOR TAB-PROFEN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for TAB-PROFEN

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03199417 ↗ Trial Evaluating multimOdal toPical Cream In CompArison to pLacebo (TOPICAL) Terminated McMaster University Phase 2/Phase 3 2017-05-01 Randomized controlled trial regarding the efficacy of a multimodal topical analgesic, Multiprofen, in comparison to placebo cream treatment on knee pain and function in patients with knee osteoarthritis.
NCT03199417 ↗ Trial Evaluating multimOdal toPical Cream In CompArison to pLacebo (TOPICAL) Terminated Oakville Trafalgar Memorial Hospital Phase 2/Phase 3 2017-05-01 Randomized controlled trial regarding the efficacy of a multimodal topical analgesic, Multiprofen, in comparison to placebo cream treatment on knee pain and function in patients with knee osteoarthritis.
NCT03199417 ↗ Trial Evaluating multimOdal toPical Cream In CompArison to pLacebo (TOPICAL) Terminated University of Michigan Phase 2/Phase 3 2017-05-01 Randomized controlled trial regarding the efficacy of a multimodal topical analgesic, Multiprofen, in comparison to placebo cream treatment on knee pain and function in patients with knee osteoarthritis.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for TAB-PROFEN

Condition Name

Condition Name for TAB-PROFEN
Intervention Trials
Knee Osteoarthritis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for TAB-PROFEN
Intervention Trials
Osteoarthritis, Knee 1
Osteoarthritis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for TAB-PROFEN

Trials by Country

Trials by Country for TAB-PROFEN
Location Trials
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for TAB-PROFEN

Clinical Trial Phase

Clinical Trial Phase for TAB-PROFEN
Clinical Trial Phase Trials
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for TAB-PROFEN
Clinical Trial Phase Trials
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TAB-PROFEN

Sponsor Name

Sponsor Name for TAB-PROFEN
Sponsor Trials
McMaster University 1
Oakville Trafalgar Memorial Hospital 1
University of Michigan 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for TAB-PROFEN
Sponsor Trials
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.